title: Meeting report: high-throughput technologies for in vivo imaging agents.
abstract: Combinatorial chemistry and high-throughput screening have become standard tools for discovering new drug candidates with suitable pharmacological properties. Now, those same technologies are starting to be applied to the problem of discovering novel in vivo imaging agents. Important differences in the biological and pharmacological properties needed for imaging agents, compared to those for a therapeutic agent, require new screening methods that emphasize those characteristics, such as optimized residence time and tissue specificity, that make for a good imaging agent candidate.
authors.affiliation: University of Arizona, Tucson, AZ, USA.
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Gillies
authors.forename: John M
authors.initials: JM
authors.lastname: Hoffman
authors.forename: Kit S
authors.initials: KS
authors.lastname: Lam
authors.forename: Anne E
authors.initials: AE
authors.lastname: Menkens
authors.forename: David R
authors.initials: DR
authors.lastname: Piwnica-Worms
authors.forename: Daniel C
authors.initials: DC
authors.lastname: Sullivan
authors.forename: Ralph
authors.initials: R
authors.lastname: Weissleder
mesh_terms: D000818:Animals; D020650:Combinatorial Chemistry Techniques / Q000379:methods / Q000639:trends*; D019295:Computational Biology; D003287:Contrast Media; D003952:Diagnostic Imaging; D046228:Microarray Analysis; D023421:Models, Animal; D013678:Technology, Pharmaceutical / Q000379:methods / Q000639:trends*; D015027:Zebrafish
chemical_list: D003287:Contrast Media